Clinical trial

Study to Evaluate D-1553 in Subjects With Lung Cancer

NCT05383898

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-03-16

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2021-03-16Date precision: day

Registry last updated2024-10-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

NSCLCunresolved

Interventions

D-1553DRUG

Sponsors & collaborators

InventisBio Co., Ltdlead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1 HangzhouZhejiang, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05383898 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.